Adial Pharmaceuticals, Inc. Shares Outstanding (Cover Page)
Adial Pharmaceuticals, Inc. (ADIL) had Shares Outstanding (Cover Page) of 2.63 million shares as of 2026-08-12, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-12: Entity Common Stock, Shares Outstanding 2.63M shares.
- 2026-05-06: Entity Common Stock, Shares Outstanding 2.14M shares.
- 2026-03-04: Entity Common Stock, Shares Outstanding 1.43M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 23.99M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-12 | 2.63M shares 10-Q · filed 2026-08-14 |
| 2026-05-06 | 2.14M shares 10-Q · filed 2026-05-08 |
| 2026-03-04 | 1.43M shares 10-K · filed 2026-03-05 |
| 2025-11-07 | 23.99M shares 10-Q · filed 2025-11-13 |
| 2025-08-08 | 21.83M shares 10-Q · filed 2025-08-13 |
| 2025-05-13 | 7.90M shares 10-Q · filed 2025-05-14 |
| 2025-02-28 | 6.57M shares 10-K · filed 2025-03-04 |
| 2024-11-12 | 6.41M shares 10-Q · filed 2024-11-13 |
| 2024-08-12 | 6.40M shares 10-Q · filed 2024-08-13 |
| 2024-03-29 | 4.05M shares 10-K · filed 2024-04-01 |
| 2023-11-09 | 1.22M shares 10-Q · filed 2023-11-14 |
| 2023-08-18 | 1.22M shares 10-Q/A · filed 2023-10-30 |
| 2023-05-12 | 28.52M shares 10-Q · filed 2023-05-12 |
| 2023-03-30 | 28.52M shares 10-K · filed 2023-03-30 |
| 2022-11-14 | 26.85M shares 10-Q · filed 2022-11-14 |
| 2022-08-12 | 25.85M shares 10-Q · filed 2022-08-15 |
| 2022-05-13 | 23.79M shares 10-Q · filed 2022-05-16 |
| 2022-03-23 | 23.72M shares 10-K · filed 2022-03-28 |
| 2021-11-12 | 20.77M shares 10-Q · filed 2021-11-15 |
| 2021-08-12 | 20.30M shares 10-Q · filed 2021-08-12 |
| 2021-05-14 | 17.50M shares 10-Q · filed 2021-05-17 |
| 2021-03-22 | 17.27M shares 10-K · filed 2021-03-22 |
| 2020-11-13 | 14.22M shares 10-Q · filed 2020-11-13 |
| 2020-08-13 | 13.56M shares 10-Q · filed 2020-08-13 |
| 2020-05-13 | 10.63M shares 10-Q · filed 2020-05-14 |
| 2020-03-20 | 10.48M shares 10-K · filed 2020-03-20 |
| 2019-11-14 | 10.32M shares 10-Q · filed 2019-11-14 |
| 2019-08-13 | 10.24M shares 10-Q · filed 2019-08-13 |
| 2019-05-13 | 10.22M shares 10-Q · filed 2019-05-13 |
| 2019-02-15 | 7.23M shares 10-K · filed 2019-02-19 |
| 2018-11-13 | 6.56M shares 10-Q · filed 2018-11-14 |
| 2018-09-06 | 6.56M shares 10-Q · filed 2018-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |